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Background: Peanut consumption favorably influences satiety. This study examined the acute effect of peanut
versus grain bar preloads on postmeal satiety and glycemia in healthy adults and the long-term effect of these
meal preloads on body mass in healthy overweight adults.
Methods: In the acute crossover trial (n = 15; 28.4 ± 2.9 y; 23.1 ± 0.9 kg/m2), the preload (isoenergetic peanut or
grain bar with water, or water alone) was followed after 60 min with ingestion of a standardized glycemic test
meal. Satiety and blood glucose were assessed immediately prior to the preload and to the test meal, and for two
hours postmeal at 30-min intervals. In the parallel-arm, randomized trial (n = 44; 40.5 ± 1.6 y, 31.8 ± 0.9 kg/m2), the
peanut or grain bar preload was consumed one hour prior to the evening meal for eight weeks. Body mass was
measured at 2-week intervals, and secondary endpoints included blood hemoglobin A1c and energy intake as
assessed by 3-d diet records collected at pre-trial and trial weeks 1 and 8.
Results: Satiety was elevated in the postprandial period following grain bar ingestion in comparison to peanut or
water ingestion (p = 0.001, repeated-measures ANOVA). Blood glucose was elevated one hour after ingestion of the
grain bar as compared to the peanut or water treatments; yet, total glycemia did not vary between treatments in
the two hour postprandial period. In the 8-week trial, body mass was reduced for the grain bar versus peanut
groups after eight weeks (−1.3 ± 0.4 kg versus −0.2 ± 0.3 kg, p = 0.033, analysis of covariance). Energy intake was
reduced by 458 kcal/d in the first week of the trial for the grain bar group as compared to the peanut group (p = 0.118).
Hemoglobin A1c changed significantly between groups during the trial (−0.25 ± 0.07% and −0.18 ± 0.12% for the grain
bar and peanut groups respectively, p = 0.001).
Conclusions: Compared to an isoenergetic peanut preload, consumption of a grain bar preload one hour prior to a
standardized meal significantly raised postmeal satiety. Moreover, consumption of the grain bar prior to the evening
meal was associated with significant weight loss over time suggesting that glycemic carbohydrate ingestion prior to
meals may be a weight management strategy.
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Between 1980 and 2004, obesity prevalence doubled in the
U.S., and the most recent statistics show that 28% of
Americans are obese, up from 23% in 2004 [1]. For adults
20 years and older, the prevalence is higher at 34% [2]. Al-
though much time and effort has been directed at devel-
oping weight loss diets or exercise programs that promote
successful weight loss, these attempts have been largely
unsuccessful, in part because individuals are not willing to
make (and sustain) major dietary and/or lifestyle changes.
This futileness is evident in the U.S. Department of Health
and Human Service’s 2010 and 2020 Healthy People tar-
gets for reducing adult obesity prevalence in the U.S., 15%
and 30.6% respectively. New approaches for combating
obesity are needed. Identifying simple, unintimidating diet
strategies to help individuals control hunger may be a use-
ful approach to weight management.
Early survey data showed that Americans who con-
sumed five or more servings of peanuts and/or tree nuts
per week were thinner than those who consumed these
products less often [3,4]. These foods are micronutrient
dense and high protein, characteristics that influence sa-
tiety and energetics [5-7]. Peanuts and tree nuts also re-
duce meal-induced glycemia, a characteristic that may
contribute to their satiating effects since postprandial
glycemia has been related to both satiety and reduced
energy intake at subsequent meals [8,9]. In acute feeding
trials, peanut butter and almond ingestion at mealtime
reduced postprandial glycemia 40–50% [10-12]. Several
extended feeding trials examined the effect of tree nut
consumption on weight gain [13-15]. In these trials, par-
ticipants who incorporated 2–3 servings of peanuts or
tree nuts into their diets daily (340–500 kcal) compen-
sated for a majority of these calories by displacement of
other food items in the diet, and did not gain weight.
Hence, it appears that the high satiety value of peanuts
and tree nuts effectively regulates daily calorie intake.
Although there is general consensus that peanut and
tree nut ingestion have measurable effects on energetics,
these trials do not explain the survey data that related
body thinness to peanut and nut consumption. In these
surveys, the quantity of peanuts/nuts consumed by indi-
viduals was much less than that used in the experimental
trials, less than one serving per day versus 2–3 servings
per day. To date, a randomized clinical trial has not been
conducted to explore the impact of modest peanut con-
sumption (170 kcal or 28 g, an amount equivalent to one
serving per day) on body weight. It is possible that a single
serving of peanuts or tree nuts daily would have a satiating
effect with fewer calories, a combination that may pro-
mote modest weight loss over time.
This study examined the acute effect of peanut ingestion
(23 g) on postmeal satiety in healthy adults, and the long-
term satiating effect of daily peanut ingestion (28 g/d) onbody mass over an 8-week period in overweight adults. For
both trials, the peanuts were ingested as a preload one hour
prior to mealtime to capitalize on their purported satiating
effects. Others have demonstrated that a protein preload at
30, 120, or 180 minutes prior to a meal was not associated
with reductions in total energy intake (e.g., energy of pre-
load +meal) whereas a protein preload administered at 1
hour prior to a meal reduced total energy intake by as
much as 134 kcal [16-18]. A prepackaged, carbohydrate-
rich, grain-based snack bar (140 kcals) was selected as the
control treatment as it was shown to have neutral effects
on body weight in a long-term feeding trial [15].
Methods
Healthy, non-smoking adults aged 20–65 y who were
not diabetic by self-report and who did not have known
peanut or tree nut allergies were recruited for these tri-
als from a campus community. Eligible volunteers did
not report a recent history of dieting and/or change in
body weight (±5 kg), prescription drug use that impacted
eating behavior or body weight, more than three high-
intensity exercise sessions per week, or unresolved med-
ical conditions and disease. Sixty-four overweight or
obese volunteers (body mass index [BMI] >25 kg/m2)
entered the 8-week trial, and a separate pool of volun-
teers (n = 15; BMI, 18–30 kg/m2) entered the acute trial.
Written informed consent was obtained from all partici-
pants, and the study was approved by the Institutional
Review Board at Arizona State University.
Acute trial
Participants consumed a standard dinner meal (sub sand-
wich, soda, and cookie) the night before testing and fasted
overnight (no food or beverage with the exception of water
for >10 h). At the test site, fasting participants were
assigned to one of three treatments using a randomized
block design: ingestion of 23 g (0.82 oz; 140 kcal) peanuts
with 1 c water followed after 60 minutes with ingestion of a
buttered bagel and juice; ingestion of one grain bar (140
kcal) with 1 c water followed after 60 minutes with inges-
tion of a buttered bagel and juice; or, ingestion of 1 c water
followed after 60 minutes with ingestion of a buttered bagel
and juice. The standardized test meal was composed of
commercially purchased foods (bagel, 114 g; berry juice,
200 g; and margarine, 14 g) and contained 460 kcal (68%
carbohydrate, 23% fat, 9% protein).
Blood was collected immediately before peanut/grain
bar/water ingestion, immediately before bagel ingestion,
and at 30-minute intervals for the 2-h period after inges-
tion of the bagel meal. Perceived satiety was assessed at
these same intervals during the trial using a validated
Likert scale [19]. Blood was analyzed for glucose at each
time point and for insulin at three time points: pre-
peanut/grain bar ingestion, pre-meal ingestion, and
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three weeks, and each participant reported to the test site
weekly and followed the same protocol to complete all
treatments. Each week, all treatments were examined with
one-third of participants receiving the same treatment.
During the 3-week trial period, participants were asked to
maintain their normal activities but to record all food and
beverage consumption on the three treatment days.
Long-term trial
The 8-week trial employed a parallel arm design. Partici-
pants were paired by age, gender, and BMI, and paired
individuals were randomly assigned to the treatment
groups: peanut or grain bar. To encourage a standard
diet plan across groups, all participants received food-
based, low-fat diet counseling as outlined in the U.S.
Dietary Guidelines and using the participant’s calculated
basal metabolic rate. All participants received the same
instructions for consuming the test food 60 minutes
prior to the dinner meal daily during the trial. Partici-
pants met with study investigators at baseline and at
weeks 2, 4, 6, and 8 for anthropometric assessment and
food pick-up. On the three days immediately preceding
the start of the trial, the first three days of the trial, and
at trial week 8, participants were asked to complete 3-d
diet records. At the end of the 8-week trial, participants
were encouraged to continue the feeding protocol and
return for follow-up testing at 12 and 16 weeks. A
fasting blood sample was collected at baseline, week 8,
and week 16 and analyzed for glucose, hemoglobin A1c,
and insulin. Participants were asked to record discre-
tionary physical activities daily during the trial (type and
duration) and to bring this recorded log to the test site
biweekly along with the written diet records. The phys-
ical activities were assigned an energy value to estimate
daily discretional energy expenditure.
Test foods
The test foods, individual packets of peanuts (1 oz) and
grain bars (1.4 oz), were purchased from commercial
outlets and shelf-stable; one prepackaged item equaled
the preload serving size in the long-term trial eliminat-
ing the need for participants to measure the preload por-
tion. Test foods were supplied to participants at two week
intervals during the 8-week trial. Participants were also of-
fered their respective test foods during the follow-up
period, weeks 8 through 16. The test food daily dosages
for the long-term trial were 28 g peanuts (Kraft Foods,
East Hanover, NJ: 170 kcal, 5 g total carbohydrate, 15 g
total fat, 2 g saturated fat, 7 g protein, 115 mg sodium,
and 2 g fiber) and 40 g grain bar (Target Brands, Inc, Min-
neapolis, MN: 140 kcals, 25 g total carbohydrate, 3 g total
fat, 0 g saturated fat, 2 g protein, 130 mg sodium, and 2 g
fiber). Identical foods were used as the preloads in theacute trial; however, the peanut dosage was reduced to
23 g to keep isoenergetic with the grain bar and eliminate
energy as a confounding factor between preloads.Measures and chemical analyses
Body composition measures (weight in light clothing and
body fat percentage) were collected at baseline for both tri-
als (bioelectrical impedance methods; Tanita scale, Model
TBF-300A, Tanita Corp, Arlington Heights, IL). In the
long-term trial, body composition measures were also col-
lected at trial weeks 2, 4, 6, and 8, as well as at weeks 12
and 16 of the follow-up period. Waist circumference was
measured at the umbilicus using a flexible tension tape. In
the acute trial, capillary glucose was measured using a cali-
brated OneTouch glucometer (LifeScan Inc., Milipitas,
CA); serum insulin concentrations were assessed by radio-
immunoassay (Millipore, St. Charles, MO). For the long-
term trial, fasting blood samples were analyzed for serum
glucose using a COBAS C111 chemistry analyzer (Roche
Diagonstics, Indianapolis, IN) and hemoglobin A1c using
an autoanalyzer (DCA200+, Siemens Healthcare Diagnos-
tics Inc. Deerfield, IL). Serum insulin concentrations were
assessed as outlined for the acute trial.Statistical analyses
Results are expressed as means ± SE, and all data ana-
lyses were conducted using PASW Statistics 19.0, (Pre-
dictive Analytics SoftWare Statistics package, IBM,
2009). P values ≤ 0.05 were considered significant. Based
on our previous work [20] a sample size of 15 in the
acute trial provided an 88% power to observe a 16%
change in postprandial glycemia. In the acute trial, total
satiety for the postprandial period (0–120 min) was cal-
culated as the area-under-the-curve (AUC) using the
trapezoidal rule. Postprandial glycemia (0–120 min) was
calculated as the incremental AUC (iAUC). Satiety and
glycemia data were normally distributed; insulinemia
data were normally distributed following removal of one
outlier (>3 SD from mean). Treatment effects were
assessed using the repeated-measures ANOVA test, and
the LSD posthoc test was used to identify differences be-
tween individual means.
For the long-term trial analyses, between groups ana-
lysis of covariance (ANCOVA) was used with baseline
values as the covariate. Independent t-test was used to
assess differences at baseline. Fasting glucose and insulin
were not normally distributed, and the nonparametric
Mann–Whitney test was used to evaluate change over
time between groups. Body mass data at week 8 were
assessed for completers only and by using the intention-
to-treat, Last Observation Carried Forward (LOCF),
method to impute missing values.
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Acute trial
Two men and thirteen women (28.4 ± 2.9 y; BMI, 23.1 ±
0.9 kg/m2) completed the acute trial. Serum glucose and
insulin concentrations for all participants (calculated from
fasting blood samples collected on test days) fell below cut-
offs for prediabetes (glucose <5.55 mmol/L) and insulin re-
sistance (serum insulin <18 μU/mL) (Table 1). Both peanut
and grain bar consumption were associated with greater
satiety than the control treatment after one hour (p < 0.05)
(Figure 1). Grain bar consumption was associated with
greater satiety versus peanut and control at 60 and 90 min
postmeal ingestion (p < 0.040). At 120 min, grain bar con-
sumption remained more satiating than peanut consump-
tion (p = 0.023). The 0–120 min AUC for satiety was
significantly greater for the grain bar treatment versus the
peanut and control treatments (p < 0.006) (see inset,
Figure 1). Total energy intakes were 100–120 kcal less on
days the peanuts and bars were ingested as compared to
the control treatment, but these values did not differ sig-
nificantly by treatment (1771 ± 149 kcal, 1756 ± 144 kcal;
and 1878 ± 209 kcal respectively; p = 0.709).
Mean fasting blood glucose concentrations did not differ
by treatment (range: 4.9 ± 0.1 mmol/L to 5.0 ± 0.1 mmol/L);
however, blood glucose was significantly elevated one hour
after ingestion of the grain bar (+0.8 ± 0.1 mmol/L) versus
that recorded for the peanut or control treatments (−0.1 ±
0.1 mmol/L and −0.1 ± 0.1 mmol/L, respectively) (p < 0.001;
Figure 2). At 30 min postmeal, mean blood glucose for the
control treatment was significantly greater than that for
peanut or grain bar (p < 0.050). Thereafter, no further differ-
ences in plasma glucose were noted between groups. For
the 0–120 min postprandial period, iAUC for blood glucose
did not vary between treatments (see inset, Figure 2).
The mean fasting serum insulin concentrations did
not differ by treatment (range: 3.8 ± 0.7 μU/mL to 4.1 ±
0.8 μU/mL), and the change in serum insulin during the
trial period did not differ by group (p = 0.161, repeated
measures ANOVA; Figure 3). The changes in serum in-
sulin one hour following the preloads were 8.9 ± 1.4 μU/
mL, 2.0 ± 0.5 μU/mL and −0.6 ± 0.4 μU/mL for the grain
bar, peanut, and control treatments respectively. TheTable 1 Baseline characteristics of participants in acute
glycemia trial (n = 15)1
Gender, M/F 2/13
Age, y 28.4 ± 2.9 (20–58)
Weight, kg 66.4 ± 3.6 (54–106)
Body mass index, kg/m2 23.1 ± 0.9 (18–31)
Serum fasting glucose, mmol/L 4.9 ± 0.1 (4.3–5.3)
Serum fasting insulin, μU/mL 4.2 ± 0.7 (2–10)
1Data represent mean ± SE; range in parentheses. Glucose and insulin
concentrations were averaged from 3 fasting samples and not correlated to
age, weight, or body mass index.incremental rise in serum insulin at 30 min following in-
gestion of the bagel and juice meal did not differ among
treatments (range: 32–39 μU/mL).
Long-term trial
Of the 64 individuals enrolled in the trial, four did not
start the trial and ten dropped out during the first two
weeks of the trial. There were no significant differences
by gender, age, weight, BMI, or body fat percentage be-
tween participants who remained in the trial at week 2
and those who did not. An additional six individuals did
not keep all appointments for the biweekly visits through
week 8. Personal reasons were cited as the cause of this
attrition. Data are presented for the 44 participants who
completed the 8-week trial (n = 23 [9 males], peanut
group; n = 21 [7 males], grain bar group) (Table 2). Food
record analyses (i.e., the fraction of records that listed the
test food) suggested that compliance rates for the food in-
terventions were 94% and 67% at week 1 (p = 0.092) and
82% and 74% at week 8 (p = 0.823) for the peanut and
grain bar groups respectively. Estimated energy expend-
iture for discretionary physical activity did not differ be-
tween groups during week 1 of the study (138 ± 19 kcal/d
and 116 ± 19 kcal/d for peanut and bar groups respect-
ively), and energy expenditure did not change between
groups during the study (131 ± 29 kcal/d and 112 ± 17
kcal/d respectively at week 8; p = 0.898 for interaction).
Mean values for body weight, body fat percentage, and
waist circumference decreased for participants at the
end of the 8-week trial. Gender, but not age, was related
to weight loss; hence, gender was entered as a covariate
in all analyses. The decrease in body weight was signifi-
cantly greater for the grain bar participants versus the
peanut participants (−1.3 ± 0.4 kg [range: -5.3 to +1.8 kg]
and −0.2 ± 0.3 kg [range: -3.8 to +2.5 kg] respectively;
p = 0.033) (Table 2). Using the intention-to-treat LOCF
method to impute missing values at week 8, the signifi-
cance between groups for weight loss was strengthened
(p = 0.008). However, after the 8-week follow-up period,
the change in body weight between groups was no lon-
ger significant (Figure 4). At the end of the 8-week
follow-up period, a statistical trend for change in body
fat percentage between groups was evident with a
greater reduction in body fat noted for the grain bar
group as compared to the peanut group (−1.6 ± 0.5%
and −0.5 ± 0.3% respectively, p = 0.089) (Table 2). Waist
circumferences did not vary significantly between groups
during the trial (Table 2).
The mean energy intake for the three days immedi-
ately prior to the start of the trial did not differ by group
(1706 ± 112 kcal/d and 1715 ± 134 kcal/d, peanut and
grain bar groups respectively) (Table 3). During the first
3 days of the trial, the mean daily energy intake in the
grain bar group fell 359 ± 177 kcal/d relative to baseline
-60        -30      0        30       60      90       120
minutes
Peanut Bar Control
greatest imaginable fullness
extremely full
very full
moderately full
slightly full
neitherhungry nor full
slightly hungry
moderately hungry
very hungry
extremely hungry
greatest imaginable hunger
**
** **
*
‡
AUC
0-120 min
Figure 1 Perceived satiety during the acute trial (mean ± SE; n = 15). At time 0 the test meal was consumed, which was exactly one hour
after ingestion of the control treatment (1 c water) or the peanut or grain bar treatments, each with 1 c water. Satiety curves differed significantly
(repeated measures ANOVA, time x group interaction; p = 0.002). The area-under-curve for 0–120 minutes differed by treatment (see inset; p = 0.003).
* satiety for control treatment significantly less than that for peanut or grain bar (p < 0.05). ** satiety for grain bar significantly greater than that for
peanut or grain bar (p < 0.05). ‡ satiety for grain bar significantly greater than that for peanut (p = 0.023).
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Figure 2 Incremental serum glucose for the acute trial (mean ± SE; n = 15). At time 0 the test meal was consumed, which was exactly one
hour after ingestion of the control treatment (1 c water) or the peanut or grain bar treatment, each with 1 c water. Incremental plasma glucose
curves differed significantly (repeated measures ANOVA, time x group interaction; p = 0.023). The incremental area-under-curve for 0–120 minutes
did not differ by treatment (see inset; p = 0.901). * glucose excursion for grain bar significantly greater than that for peanut or control (p < 0.001).
** glucose excursion for control significantly greater than that for peanut or grain bar (p < 0.05).
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Figure 3 Incremental plasma insulin concentrations for the
acute trial (mean ± SE; n = 13). At time 0 the test meal was
consumed, which was exactly one hour after ingestion of the
control treatment (1 c water) or the peanut or grain bar treatment,
each with 1 c water. Incremental plasma insulin did not differ
between groups (repeated measures ANOVA, time x group
interaction; p = 0.268).
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the peanut group (p = 0.118 for interaction; Table 3). At
week 8, mean daily energy intakes for both groups were
within 80 kcal of the baseline value. Protein and fiber in-
takes (g/d) tended to increase in the peanut group in the
first week of the trial as compared to intakes in the grain
bar group (0.05 < p < 0.10; Table 3).
Hemoglobin A1c was reduced 0.25 ± 0.07% in the grain
bar group versus a reduction of 0.18 ± 0.12% in the peanut
group (p = 0.001; Table 2). This significance between
groups was retained after controlling for the change in
body weight over the same period (p = 0.006); however,
follow-up data collected eight weeks after the trial ended
indicated that the change from baseline for hemoglobin
A1c was no longer different between groups (Table 2).
Discussion
Cross-sectional studies have associated numerous health
benefits with regular nut consumption [7,21], and the lit-
erature describing the inverse association between nut
consumption and body weight is robust [22-24]. Theo-retical explanations for this association include enhanced
satiety and caloric compensation, a strong thermic re-
sponse following ingestion, and incomplete digestion
with enhanced fecal fat losses [5,7,25]. Yet, randomized
intervention trials that have examined the impact of daily
nut consumption on body weight demonstrated only neu-
tral effects [13-15,26-29], possibly a consequence of the
high caloric value of the nut allotments (240–1374 kcal). In
the present report, the nut dosage was modest (1 serving
or 170 kcal) and consumed as a preload 1-hour prior to
mealtime to maximize purported satiety potential; however,
daily nut ingestion did not impact body weight over time.
The favorable effects of grain bar ingestion, the control
treatment, in both the acute and long-term trials were un-
expected as others have used this control treatment with
neutral effects [15]. Furthermore, preloads composed of
glycemic carbohydrate increased energy consumption at
mealtime in several studies [17,30]. In the acute trial, in
comparison to the peanut and/or water treatments, grain
bar consumption one hour prior to the test meal was
associated with greater perceived satiety at 60, 90, and
120 minutes postmeal and with greater blood glucose con-
centrations at the time the test meal was consumed. Thus,
grain bar ingestion was associated with a strong, sustained
satiety response that was not observed for peanut inges-
tion. The observed increase in perceived satiety noted with
the consumption of a food item that displays a relatively
high-glycemic-response contradicts a body of literature
demonstrating that postprandial glycemia is directly asso-
ciated with appetite [8,9,31,32].
Anderson and colleagues [33] proposed an explanation
for these seemingly contradictory responses by sugges-
ting that high glycemic carbohydrates promote satiety in
the short-term (one hour after ingestion) whereas low
glycemic carbohydrates are associated with a delayed sa-
tiety (2 to 3 hours post-ingestion) consistent with their
delayed impact on blood glucose concentrations. Indeed,
controlled trials demonstrate increased fullness [34] and
lower mealtime energy intakes [35] one hour after the
ingestion of high glycemic preloads versus low glycemic
preloads and three hours after the ingestion of a fiber-
rich carbohydrate preload versus an isocaloric bread pre-
load [36]. Furthermore, the glucostatic theory, proposed
by Mayer in 1952 [37], suggested that food intake is reg-
ulated by glucoreceptors in the hypothalamus that sense
glucose utilization and adjust food intake to maintain
metabolic glucose at a steady-state. Accordingly, satiety
is maximized when blood glucose concentrations are high.
Hence, the timing of the preloads in the present report
(one hour prior to a meal) likely contributed to the strong
satiating effects of the grain bar 1.5 hours later.
Interestingly, although both glucose and insulin con-
centrations were significantly elevated 1-hour following
the ingestion of the grain bar as compared to peanut or
Table 2 Change from baseline in participant characteristics at the end of the 8-week trial and at follow-up at week 16
by treatment group1
n2 wk8/wk16 Baseline Week 8 p Week 16 p
Body weight, kg*
Peanut 23/23 87.0 ± 3.9 −0.2 ± 0.3 0.033 0.2 ± 0.5 0.196
Grain bar 21/19 82.5 ± 3.7 −1.3 ± 0.4 −1.0 ± 0.6
Body fat, %*
Peanut 23/23 40.0 ± 1.7 −0.4 ± 0.3 0.429 −0.5 ± 0.3 0.089
Grain bar 21/19 40.6 ± 1.3 −0.7 ± 0.4 −1.6 ± 0.5
Waist circumference, cm*
Peanut 22/20 104.6 ± 2.9 −4.1 ± 1.1 0.254 −5.9 ± 1.6 0.495
Grain bar 21/18 99.5 ± 2.2 −1.5 ± 1.0 −4.4 ± 1.2
Serum fasting glucose, mmol/L
Peanut 23/21 5.5 ± 0.4† −0.4 ± 0.3 0.254 −0.4 ± 0.3 0.554
Grain bar 21/18 5.0 ± 0.5 −0.1 ± 0.1 −0.02 ± 0.12
Hemoglobin A1c, %*
Peanut 22/20 5.67 ± 0.27 −0.18 ± 0.12 0.001 −0.16 ± 0.15 0.159
Grain bar 21/18 5.35 ± 0.10 −0.25 ± 0.07 −0.07 ± 0.06
Serum fasting insulin, uM
Peanut 23/21 22.5 ± 2.7 −1.5 ± 2.5 0.226 9.9 ± 13.3 0.632
Grain bar 21/18 20.8 ± 4.5 −6.5 ± 3.9 −7.1 ± 4.8
1Data represent mean ± SE. P values for ANCOVA with baseline value as covariate; data not normally distributed (glucose and insulin) assessed for change by
treatment using non-parametric Mann–Whitney test. *Indicates significant time effect at week 8 (repeated measures ANOVA). †Indicates significant difference at
baseline between groups. 2Data shown for participants completing the 8-week trial (n = 23 and 21 for peanut and grain bar groups respectively). Reduced sample
sizes indicate attrition at follow-up and/or missing data point.
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glucose during the postprandial period (0–120 min
postmeal) did not differ significantly between treatments.
However, it is likely that these results do not accurately
portray the magnitude of total glycemia following grain* * * *
*
Figure 4 Change from baseline for body weight during the
8-week trial and the subsequent 8-week follow-up period. Data for
trial weeks 2–8 represent participants who completed the 8-week trial
(n = 23 and 21 for peanut and grain bar group respectively). Follow-up
data represent 23/19 and 21/18 participants for peanut/grain bar groups
at weeks 12 and 16 respectively. 8LOCF data represents the intention-to
-treat LOCF method at week 8 (n = 26 and 24 for peanut and grain bar
groups). Asterisks indicate significant difference between groups (p < 0.05).bar ingestion since blood samples were not collected at
the 30-minute interval after preload ingestion. Regard-
less, grain bar ingestion had an immediate, glycemic and
insulinemic response that was not sustained once the
test meal was ingested.
The rise in both blood glucose and insulin one hour
after grain bar ingestion coincided with the test meal
ingestion and may have contributed to the attenuation
of the postprandial glycemic response and to the rise
in satiety ratings. Following nut ingestion a rise in insu-
lin but not glucose concentrations was observed at
60 minutes, and although postprandial glycemia at
30 min was similar to the grain bar treatment, per-
ceived satiety was not impacted throughout the post-
prandial period relative to control. The insulintropic
action of dietary protein is well documented and believed
to relate to bioactive peptides or specific amino acids
[38-40]. The rise in insulin following peanut ingestion may
have abetted the reduction in postmeal glycemia, but the
absence of a glycemic response prior to the ingestion of
the test meal may be linked to the low satiety ratings
observed for peanut ingestion.
Glucagon-like peptide (GLP)-1, an incretin hormone
released from mucosal cells in response to nutritive and
non-nutritive agents, contributes to the suppression of
appetite during the postprandial period by direct central
Table 3 Change from baseline in 24-h intakes at trial week 1 and trial week 8 by treatment group1,2
n3 wk1/wk8 Baseline Change at week 1 P Change at week 8 P
Energy intake, kcal
Peanut 15/15 1706 ± 112 99 ± 201 0.118 77 ± 161 0.409
Grain bar 13/19 1715 ± 134 −359 ± 177 −69 ± 139
Protein intake, g
Peanut 15/15 67 ± 4 9 ± 8 0.070 7 ± 6 0.218
Grain bar 13/19 67 ± 6 −7 ± 8 −1 ± 5
Carbohydrate intake, g
Peanut 15/15 230 ± 18 −0.3 ± 18.4 0.144 −17 ± 18 0.605
Grain bar 13/19 223 ± 18 −49 ± 23 −22 ± 14
Fat intake, g
Peanut 15/15 57 ± 5 7 ± 9 0.172 13 ± 9 0.667
Grain bar 13/19 62 ± 6 −15 ± 8 3 ± 10
Fiber intake, g
Peanut 15/15 17 ± 2 3 ± 2 0.087 0.2 ± 1.6 0.672
Grain bar 13/19 17 ± 2 −1 ± 2 1 ± 2
1Data represent mean ± SE. P values for ANCOVA with baseline value as covariate. There were no significant differences between groups at baseline or during the
trial. 2Three day diet records were kept prior to the start of the trial (baseline), at week 1 (the first 3 days of the trial), and at week 8. 3Reduced sample sizes reflect
missing diet records.
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present report, others have shown that carbohydrates
and nuts appear to have differing effects on GLP-1 re-
lease, a fact that may help explain the results reported
herein. Stimulation of the sodium-glucose cotransporter-1
is believed to play a role in GLP-1 release [42] and both
high-glycemic and low-glycemic carbohydrates effectively
stimulate GLP-1 release, an effect which is sustained for
over 3 hours [35,43]. Nut ingestion, however, displayed a
more moderate effect on GLP-1 release, and blood con-
centrations fell to below baseline after 60 minutes [44].
Further studies examining the role of preloads in promot-
ing postmeal satiety and incretin hormone release are
needed to elucidate mechanisms.
In the 8-week trial, a single serving of peanuts (170 kcal)
or the control treatment, a grain bar (140 kcal), were
ingested in a structured manner, one hour prior to the
evening meal. Theoretically, consuming a modest serving
of peanuts as a preload to the evening meal would
maximize their purported satiating effects and possibly
contribute to weight loss over time [16,17]. However, con-
sistent with the previous trials, daily consumption of nuts
did not impact 24-h energy intakes or body weight. It may
be that greater quantities of nuts (>48 g) are necessary to
increase satiation [26,45]; but, given the caloric load of this
quantity of nuts, measurable losses in body mass are not
likely to be noted, at least over the short-term. Surpris-
ingly, daily grain bar ingestion did reduce body weight sig-
nificantly after 8 weeks. The favorable impact of grain bar
ingestion on body weight was also noted at study weeks 2
and 6 as well as at the 4-week follow-up (Figure 3).The success of grain bar ingestion for managing en-
ergy intake was realized early in the trial. Although the
change from baseline for mean energy intakes in the first
week of the trial did not differ significantly between
groups, the change in energy intake was weakly related
to change in body weight at week 2 for all participants
(r = 0.339, p = 0.077). The decision to preload the even-
ing meal in this trial may have revealed an unforeseen
benefit. The significant reductions in mid-day mealtime
energy intakes reported by Farajian et al. [37] for a fiber-
rich carbohydrate preload were not sustained after a 24 h
period indicating that energy compensation occurred later
that day. In the present trial, by preloading the final meal
of the day, the mealtime energy reductions related to the
grain bar preload appeared not to have been compensated
for prior to bedtime. Moreover, daily grain bar ingestion
lowered hemoglobin A1c significantly after 8 weeks com-
pared to peanut ingestion. The favorable impact for regu-
lar grain bar ingestion on diabetic biomarkers is novel and
deserves further investigation.
Limitations of this study include the use of diet re-
cords to estimate energy intakes and compliance to the
feeding study protocol. Although compliance did not dif-
fer significantly between groups, compliance may have
impacted study outcomes. However, the significance for
weight loss between groups was retained when only the
compliant participants were examined (p = 0.047). Partici-
pants were overweight but healthy by self-report; hence,
these results may not apply to normal weight populations
or those with cardiovascular disease or diabetes. When
considering the glucostatic theory as presented by Mayer
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diabetic state; hence, a glycemic carbohydrate preload one
hour prior to mealtime may not curb hunger in individ-
uals with insulin resistance or diabetes. However, study
participants were free-living allowing for natural eating be-
haviors and contributing to the external validity of the
study. The lack of glucose and insulin data at 30 minutes
following the ingestion of the preloads is another import-
ant limitation in this trial. Future trials should closely
follow satiety and glycemic responses after preload inges-
tion and prior to meal ingestion. Trials of longer duration
(6–12 months) are needed to better understand the role of
glycemic carbohydrate preloads for weight management,
and the measurement of the satiety peptides, e.g., GLP-1,
will provide useful physiological information regarding
mechanisms.
These data indicate that a low-energy, glycemic carbo-
hydrate preload to the evening meal reduced 24-h en-
ergy intakes in healthy, overweight adults, resulting in
significant reductions in body weight. A peanut preload
(28 g) did not impact 24-h intakes or body weight in this
population. Simple, inexpensive, and practical weight loss
strategies, easily adopted by children and adults across di-
verse populations groups, are needed to help combat
obesity. Although glycemic carbohydrates are a controver-
sial topic in the recent literature, low-energy, glycemic car-
bohydrates may have a useful role as a preload. More
research is needed to investigate the usefulness of preloads
on eating behaviors and weight loss.
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